Maruyama Y, Feola J M, Tai D, Wilson L C, Van Nagell J R, Yoneda J
Oncology. 1978;35(4):172-8. doi: 10.1159/000225280.
Clinical data about therapy concerning tumors of the female gynecological cancers of the cervix, vagina and uterus are reviewed. Dosimetric, laboratory and radiobiological research data form the basis for an approach to such tumors using Cf-252 as a form of boost brachytherapy. Extreme personnel hazards are a real and important consideration and indicate that maximal containment and isolation procedures should be exercised in its use. But it is anticipated that new possibilities for successful radiotherapy of an important cagegory of tumor will be realised by its clinical evaluation and application.
本文综述了关于子宫颈、阴道和子宫女性妇科癌症肿瘤治疗的临床数据。剂量学、实验室和放射生物学研究数据构成了使用Cf - 252作为一种后装近距离放射治疗形式来治疗此类肿瘤方法的基础。极端的人员危害是一个现实且重要的考虑因素，这表明在使用它时应采取最大程度的防护和隔离措施。但预计通过其临床评估和应用，将为一类重要肿瘤的成功放射治疗带来新的可能性。
